Drug company to pay $3 billion to settle criminal charges
Jul 02, 2012
In what is the biggest healthcare fraud settlement in U.S. history, drugmaker GlaxoSmithKline will pay $3 billion and plead guilty to illegally promoting prescription drugs.
Analysis: Medication adherence spotty among U.S. diabetes patients
By
Alicia Lasek
Feb 01, 2023
A sizable percentage of patients with diabetes do not consistently take prescribed medications to lower cholesterol, glucose or blood pressure, investigators say.
Statin initiation linked to greater progression of diabetes
Oct 04, 2021
Each individual component of the composite outcome was significantly higher among statin users
Popular diabetes medication linked to heart attack, death
Mar 22, 2011
A new study links the popular diabetes drug Avandia with an increased risk of heart attack and death, which could have a considerable effect on public health, according to researchers.
FDA approves ‘breakthrough’ therapy for diabetic eye disorder
By
John Hall
Mar 26, 2015
The FDA announced Wednesday that it has granted “breakthrough therapy designation” to the drug Eylea, and expanded its approved use for the treatment of diabetic retinopathy in patients with...
New guidance for treating hypoglycemia in long-term care stresses understanding of glucagon
By
Kristen Fischer
Aug 21, 2023
There’s some new guidance on treating hypoglycemia, or low blood sugar, in long-term care communities. It’s specifically geared for healthcare workers, though anyone who is a caregiver for someone...
Study eyes new cause of diabetes
By
Kristen Fischer
Dec 11, 2023
A new study sheds light into what causes diabetes and explains a new breakthrough that could offer the potential for new disease treatments.
Older adults with diabetes had worse functional declines during pandemic, study finds
By
Kristen Fischer
Apr 18, 2024
About 1 in 5 older adults with diabetes who didn’t have functional limitations before the pandemic developed them during that time. The same happened to 1 in 8 of older adults without diabetes, according...